Bristol-Myers Squibb (BMY) Tops Q1 EPS by 5c; Reaffirms Outlook
Tweet Send to a FriendGet Alerts BMY Hot Sheet
Price: $43.30 +1.24%
Revenue Growth %: -27.0%
Financial Fact:
Earnings Before Income Taxes: 513M
Today's EPS Names:
LBIX, ESEA, ISS, More
Revenue Growth %: -27.0%
Financial Fact:
Earnings Before Income Taxes: 513M
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade BMY Now!
Bristol-Myers Squibb Company (NYSE: BMY) reported Q1 EPS of $0.58, ex-items, $0.05 better than the analyst estimate of $0.53. Revenue for the quarter came in at $5.01 billion versus the consensus estimate of $4.95 billion.
Reaffirms outlook.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Reaffirms outlook.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Leerink Swann Upgrades Bristol-Myers Squibb Co. (BMY) to Outperform
- Goldman Sees Blockbuster Potential for Bristol-Myers Squibb's (BMY) Nivolumab (PD-1)
- AbbVie (ABBV) Has Plenty More Tricks Up Its Sleeve - Barron's
Create E-mail Alert Related Categories
Earnings, Hot Earnings, Hot List
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
